Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 1812

Sort by

Sort Order Select

Journal Articles

Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma

Kathryn R. Tringale, Michael Scordo, Joachim Yahalom, Charlie White, Zhigang Zhang, Javin Schefflein, Gustav Cederquist, Lauren R. Schaff, Lisa DeAngelis, Brandon S. Imber, Christian Grommes

Blood Adv (2024) 8 (24): 6195–6206.

https://doi.org/10.1182/bloodadvances.2024013780

Published: 2024

Includes: Supplemental data

Journal Articles

Guideline concordance of aspirin use for primary prevention in adult outpatients

Naina Chipalkatti, Geoffrey D. Barnes, Linda Bashaw, Adam Davie, Jennifer J. Griggs, Molly Harrod, Jacob E. Kurlander, Christine Medaugh, Rebeca Packard, Corey Powell, Suman Sood, Elizabeth Spranger, Sarah E. Vordenberg, Jordan K. Schaefer

Blood Adv (2024) 8 (24): 6207–6214.

https://doi.org/10.1182/bloodadvances.2024014220

Published: 2024

Includes: Supplemental data

Journal Articles

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Alexandra Schifferli, Gautier Le Gavrian, Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thierry Leblanc, Sébastien Héritier, Helder Fernandes, Thomas Kühne

Blood Adv (2024) 8 (24): 6183–6194.

https://doi.org/10.1182/bloodadvances.2024014381

Published: 2024

Includes: Supplemental data

Journal Articles

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Michael Andersen, Jr., Maria J. Fernandez Turizo, Laura E. Dodge, Charles Hsu, Kevin Barnum, Jonathan Berry, Jeffrey I. Zwicker, Rushad Patell

Blood Adv (2024) 8 (24): 6151–6160.

https://doi.org/10.1182/bloodadvances.2024014249

Published: 2024

Includes: Supplemental data

Journal Articles

Incidence of preexisting B-cell aplasia in B-ALL: implications for post–CAR T-cell monitoring

Isha Sahai, Paul Borgman, Bonnie Yates, Sergio Rosenzweig, Shakuntala Rampertaap, Alexander W. Rankin, Nirali N. Shah

Blood Adv (2024) 8 (24): 6329–6333.

https://doi.org/10.1182/bloodadvances.2024014641

Published: 2024

Journal Articles

Time to revisit reduced-dose radiotherapy for PCNSL?

Maciej Tatarczuch

Blood Adv (2024) 8 (24): 6234–6236.

https://doi.org/10.1182/bloodadvances.2024014588

Published: 2024

Journal Articles

Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease

Blood Adv (2024) 8 (24): 6257–6266.

https://doi.org/10.1182/bloodadvances.2024013861

Published: 2024

Journal Articles

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

Geoffrey L. Uy, Vinod Pullarkat, Praneeth Baratam, Robert K. Stuart, Roland B. Walter, Eric S. Winer, Qi Wang, Stefan Faderl, Divya Chakravarthy, Diane Menno, Ronald S. Cheung, Tara L. Lin

Blood Adv (2024) 8 (24): 6248–6256.

https://doi.org/10.1182/bloodadvances.2024013687

Published: 2024

Includes: Supplemental data

Journal Articles

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

Matthew S. Davids, Danielle M Brander, Yesid Alvarado Valero, Catherine Sibyl Diefenbach, Daniel Nathan Egan, Shira Naomi Dinner, Nathalie Javidi-Sharifi, Monzr M. Al Malki, Kebede Begna, Vijaya R. Bhatt, Sameem Abedin, Rachel Cook, Mary C. Collins, Carly Roleder, Edward C Dominguez, Prabhu Rajagopalan, Sandra E Wiley, Richard G Ghalie, Alexey V Danilov

Blood Adv bloodadvances.2024014633.

https://doi.org/10.1182/bloodadvances.2024014633

Published: 2024

Includes: Supplemental data

Journal Articles

High Pulmonary Hypertension Risk by Echocardiogram Shortens Survival in Polycythemia Vera

Alexander J Gazda, Di Pan, Katie Erdos, Ghaith Abu-Zeinah, Alexandra Racanelli, Evelyn M Horn, Joseph Michael Scandura

Blood Adv bloodadvances.2024013970.

https://doi.org/10.1182/bloodadvances.2024013970

Published: 2024

Includes: Supplemental data

Journal Articles

Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.

Ana Rita BM da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla, Patricia Eiko Yamakawa, Iara Baldim Rabelo, Louise M Arnold, Richard J Kelly, Morag Griffin, Talha Munir, Anita Hill, Elvira D R P Velloso, Thales Dalessandro, Antonio Maria Risitano, Phillip Scheinberg, Austin G Kulasekararaj, Celso Arrais-Rodrigues

Blood Adv bloodadvances.2024014159.

https://doi.org/10.1182/bloodadvances.2024014159

Published: 2024

Journal Articles

Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly-diagnosed patients: impact and outcome

Blood Adv bloodadvances.2024014999.

https://doi.org/10.1182/bloodadvances.2024014999

Published: 2024

Includes: Supplemental data

Journal Articles

Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis

Peter A. Riedell, Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna De Abia, Nausheen Ahmed, Richard T. Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J. Schuster, Andy I. Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P. McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter

Blood Adv bloodadvances.2024014164.

https://doi.org/10.1182/bloodadvances.2024014164

Published: 2024

Includes: Supplemental data

Journal Articles

The duration of iron deficiency burden

Beth MacLean, Mubashshira Ahmed, Jayne Lim, Toby Richards

Blood Adv (2024) 8 (23): 6148–6149.

https://doi.org/10.1182/bloodadvances.2024014579

Published: 2024

Journal Articles

Impact of prior treatment on CAR T-cell outcome in adult ALL

David I. Marks, Anna Z. Castleton

Blood Adv (2024) 8 (23): 6137–6138.

https://doi.org/10.1182/bloodadvances.2024014237

Published: 2024

Journal Articles

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand, Noam E. Kopmar, Chenyu Lin, Anjali S. Advani, Simone E. Dekker, Vishal K. Gupta, Timothy E. O'Connor, Nikeshan Jeyakumar, Ibrahim N. Muhsen, Yannis Valtis, Amy Zhang, Katharine Miller, Katherine Sutherland, Kaitlyn C. Dykes, Mohamed Ahmed, Evan Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M. O'Dwyer, LaQuisa C. Hill, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T. Leonard, Noelle V. Frey, Jae H. Park, Marlise R. Luskin, Veronika Bachanova, Ahmed Galal, Michael R. Bishop, Wendy Stock, Ryan D. Cassaday, Vinod Pullarkat, Bijal D. Shah, Lori S. Muffly

Blood Adv (2024) 8 (23): 6139–6147.

https://doi.org/10.1182/bloodadvances.2024013747

Published: 2024

Includes: Supplemental data

Journal Articles

The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An American Society of Hematology Initiative

Blood Adv bloodadvances.2024013945.

https://doi.org/10.1182/bloodadvances.2024013945

Published: 2024

Includes: Supplemental data

Journal Articles

Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B

Steven W. Pipe, M.D., Toshko Jelev Lissitchkov, Pencho Georgiev, Sarah Mangles, Inga Hegemann, Alice Trinchero, Pratima Chowdary, Adam Forbes, Liqi Feng, Laurel A. Menapace, Salim Kichou, Shauna Rita Andersson, Marek Demissie, Margaret V Ragni

Blood Adv bloodadvances.2024013900.

https://doi.org/10.1182/bloodadvances.2024013900

Published: 2024

Includes: Supplemental data

Journal Articles

Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study

Blood Adv bloodadvances.2024014014.

https://doi.org/10.1182/bloodadvances.2024014014

Published: 2024

Includes: Supplemental data

Journal Articles

Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma

Nadine Abdallah, Arwa Bohra, Aytaj Mammadzadeh, Francis K Buadi, Prashant Kapoor, Angela Dispenzieri, Morie A Gertz, Suzanne R Hayman, Mohammed ElHaj, David Dingli, Joselle Cook, Moritz Binder, Yi Lin, Taxiarchis V. Kourelis, Rahma Warsame, Carrie A. Thompson, Terri Menser, S. Vincent Rajkumar, Shaji K Kumar

Blood Adv bloodadvances.2024014232.

https://doi.org/10.1182/bloodadvances.2024014232

Published: 2024

Includes: Supplemental data

NARROW

Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma

Guideline concordance of aspirin use for primary prevention in adult outpatients

Sustained remission at long term follow-up in adolescents and young adults with chronic primary immune thrombocytopenia

Impact of thrombocytopenia on bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis

Incidence of preexisting B-cell aplasia in B-ALL: implications for post–CAR T-cell monitoring

Time to revisit reduced-dose radiotherapy for PCNSL?

Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

High Pulmonary Hypertension Risk by Echocardiogram Shortens Survival in Polycythemia Vera

Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.

Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly-diagnosed patients: impact and outcome

Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis

The duration of iron deficiency burden

Impact of prior treatment on CAR T-cell outcome in adult ALL

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

The Roadmap to Integrate Diversity, Equity, and Inclusion in Hematology Clinical Trials: An American Society of Hematology Initiative

Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management in people with hemophilia A or B

Trial eligibility, treatment patterns and outcome for venetoclax-based therapy in AML: a prospective cohort study

Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only